InvestorsHub Logo
Followers 104
Posts 4960
Boards Moderated 0
Alias Born 10/20/2015

Re: kzivann post# 419

Tuesday, 11/30/2021 11:28:31 PM

Tuesday, November 30, 2021 11:28:31 PM

Post# of 467
Regulus checks all the boxes for patient long term pre-revenue biotech growth/value investors. It also looks like a timely time to buy. A year out from catalysts and more than two years cash runway. Buy low and just wait for the forest to grow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RGLS News